» Articles » PMID: 38041006

Alterations in the Mammary Gland and Tumor Microenvironment of Formerly Obese Mice

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2023 Dec 1
PMID 38041006
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Obesity is a risk factor for breast cancer, and women with obesity that develop breast cancer have a worsened prognosis. Within the mammary gland, obesity causes chronic, macrophage-driven inflammation and adipose tissue fibrosis. Weight loss is a recommended intervention to resolve obesity, but the impact of weight loss on the mammary gland microenvironment and in tumors has not been well identified.

Methods: To examine the effects of weight loss following obesity, mice were fed a high-fat diet for 16 weeks to induce obesity, then switched to a low-fat diet for 6 weeks. We examined changes in immune cells, including fibrocytes, which are myeloid lineage cells that have attributes of both macrophages and myofibroblasts, and collagen deposition within the mammary glands of non-tumor-bearing mice and within the tumors of mice that were transplanted with estrogen receptor alpha positive TC2 tumor cells.

Results: In formerly obese mice, we observed reduced numbers of crown-like structures and fibrocytes in mammary glands, while collagen deposition was not resolved with weight loss. Following transplant of TC2 tumor cells into the mammary glands of lean, obese, and formerly obese mice, diminished collagen deposition and cancer-associated fibroblasts were observed in tumors from formerly obese mice compared to obese mice. Within tumors of obese mice, increased myeloid-derived suppressor cells and diminished CD8 T cells were identified, while the microenvironment of tumors of formerly obese mice were more similar to tumors from lean mice. When TC2 tumor cells were mixed with CD11bCD34 myeloid progenitor cells, which are the cells of origin for fibrocytes, and transplanted into mammary glands of lean and obese mice, collagen deposition within the tumors of both lean and obese was significantly greater than when tumor cells were mixed with CD11bCD34 monocytes or total CD45 immune cells.

Conclusions: Overall, these studies demonstrate that weight loss resolved some of the microenvironmental conditions within the mammary gland that may contribute to tumor progression. Additionally, fibrocytes may contribute to early collagen deposition in mammary tumors of obese mice leading to the growth of desmoplastic tumors.

Citing Articles

A Mediterranean diet plan in lactating women with obesity reduces maternal energy intake and modulates human milk composition - a feasibility study.

Sims C, Saben J, Martinez A, Sobik S, Crimmins M, Bulmanski J Front Nutr. 2024; 11:1303822.

PMID: 38544749 PMC: 10965561. DOI: 10.3389/fnut.2024.1303822.

References
1.
Garcia de Alba C, Buendia-Roldan I, Salgado A, Becerril C, Ramirez R, Gonzalez Y . Fibrocytes contribute to inflammation and fibrosis in chronic hypersensitivity pneumonitis through paracrine effects. Am J Respir Crit Care Med. 2014; 191(4):427-36. DOI: 10.1164/rccm.201407-1334OC. View

2.
Pilling D, Fan T, Huang D, Kaul B, Gomer R . Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One. 2009; 4(10):e7475. PMC: 2759556. DOI: 10.1371/journal.pone.0007475. View

3.
Yazhou C, Wenlv S, Weidong Z, Licun W . Clinicopathological significance of stromal myofibroblasts in invasive ductal carcinoma of the breast. Tumour Biol. 2005; 25(5-6):290-5. DOI: 10.1159/000081394. View

4.
Seo B, Bhardwaj P, Choi S, Gonzalez J, Andresen Eguiluz R, Wang K . Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis. Sci Transl Med. 2015; 7(301):301ra130. PMC: 4837896. DOI: 10.1126/scitranslmed.3010467. View

5.
Kuziel G, Moore B, Haugstad G, Arendt L . Fibrocytes enhance mammary gland fibrosis in obesity. FASEB J. 2023; 37(7):e23049. PMC: 10316715. DOI: 10.1096/fj.202300399RR. View